KEAP1 and lung carcinoid tumor: Indeed, Sparaneo et al., studying lung carcinoids (derived from the neuroendocrine system) (n = 47), found that whereas 50% exhibit KEAP1 promoter methylation, 60% present KEAP1 LOH; thus, in some tumors, both copies of KEAP1 may be inactivated [101].